O
AMPH icon

OppenheimerFunds’s Amphastar Pharmaceuticals AMPH Stock Holding History

OppenheimerFunds’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,663
Closed -$208K – 1837
2017
Q3 		$208K Sell
11,663
-649
-5% -$10.7K ﹤0.01% 1810
2017
Q2 		$220K Sell
12,312
-2,501
-17% -$39.7K ﹤0.01% 1791
2017
Q1 		$215K Buy
+14,813
New +$233K ﹤0.01% 1811
2016
Q4 		– Sell
-29,545
Closed -$560K – 1788
2016
Q3 		$560K Buy
+29,545
New +$536K ﹤0.01% 1209

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

OppenheimerFunds's AMPH Position: Q4 2017 in Review

OppenheimerFunds sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2017, closing a stake of 11,663 shares — an estimated $208K sold.

OppenheimerFunds first reported a position in AMPH in Q3 2016 and held it in 4 quarters. The position peaked at $560K in Q3 2016. 109 funds tracked by Wall St. Rank hold AMPH as of Q4 2017.

  • OppenheimerFunds reported no remaining Amphastar Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • OppenheimerFunds sold 11,663 Amphastar Pharmaceuticals shares in Q4 2017, an estimated $208K.
  • OppenheimerFunds first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 4 quarters.
  • OppenheimerFunds's Amphastar Pharmaceuticals position peaked at $560K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.